Navneet Puri, PhD

Articles by Navneet Puri, PhD

Pipeline: Presbyopia, night vision disturbance up next for Vyluma

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 24th 2021

First Vyluma product tackles pediatric myopia

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 23rd 2021

Vyluma pipeline focuses on refractive error

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 22nd 2021

Nevakar spins off ophthalmic-only company Vyluma

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Navneet Puri, PhD,Brooke Henson, Editor

June 1st 2021

A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.

Latest Updated Articles

Pipeline: Presbyopia, night vision disturbance up next for Vyluma
July 24th 2021
First Vyluma product tackles pediatric myopia
July 23rd 2021
Nevakar spins off ophthalmic-only company Vyluma
June 1st 2021
$Vyluma pipeline focuses on refractive error$
Vyluma pipeline focuses on refractive error
July 22nd 2021

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Instilling safe contact lens wearing practices in patients

How Lytenava's FDA approval will impact clinical treatment of nAMD

FDA expands TearCare indication to improve meibomian gland function

Perceived stress may precede worsening dry eye symptoms in young adults, study finds

FDA recalls eye drop that relieves ocular itch for potential contamination